We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01752049
Recruitment Status : Recruiting
First Posted : December 18, 2012
Last Update Posted : May 18, 2017
University of California, San Francisco
The Hospital for Sick Children
University of Toronto
Sunnybrook Health Sciences Centre
Ryerson University
National Institute of Neurological Disorders and Stroke (NINDS)
Information provided by (Responsible Party):
St. Michael's Hospital, Toronto

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : June 2019
  Estimated Study Completion Date : June 2019